Wedmont Private Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
22,180
+625
| +3% | +$64.4K | 0.1% | 129 |
|
|
2025
Q1 | $2.02M | Buy |
21,555
+1,319
| +7% | +$124K | 0.1% | 117 |
|
|
2024
Q4 | $1.92M | Buy |
20,236
+1,506
| +8% | +$143K | 0.1% | 116 |
|
|
2024
Q3 | $1.58M | Buy |
18,730
+1,574
| +9% | +$133K | 0.09% | 135 |
|
|
2024
Q2 | $1.33M | Buy |
17,156
+2,242
| +15% | +$174K | 0.08% | 148 |
|
|
2024
Q1 | $1.02M | Buy |
14,914
+619
| +4% | +$42.5K | 0.07% | 176 |
|
|
2023
Q4 | $835K | Buy |
14,295
+1,684
| +13% | +$98.4K | 0.07% | 196 |
|
|
2023
Q3 | $661K | Buy |
12,611
+384
| +3% | +$20.1K | 0.07% | 205 |
|
|
2023
Q2 | $648K | Buy |
12,227
+1,202
| +11% | +$63.7K | 0.07% | 192 |
|
|
2023
Q1 | $555K | Buy |
11,025
+1,127
| +11% | +$56.7K | 0.07% | 199 |
|
|
2022
Q4 | $459K | Buy |
9,898
+1,250
| +14% | +$57.9K | 0.07% | 220 |
|
|
2022
Q3 | $335K | Buy |
+8,648
| New | +$335K | 0.07% | 226 |
|
|
2022
Q2 | – | Sell |
-6,677
| Closed | -$295K | – | 342 |
|
|
2022
Q1 | $295K | Buy |
+6,677
| New | +$295K | 0.07% | 238 |
|